Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Amdocs Limited (NASDAQ:DOX). In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Amdocs stock on August 27th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Chart Industries NYSE: GTLS on 9/2/2025.
- Purchased $1,001 - $15,000 in shares of Avient NYSE: AVNT on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Intapp NASDAQ: INTA on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 8/26/2025.
- Sold $1,001 - $15,000 in shares of Fortive NYSE: FTV on 8/26/2025.
- Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 8/26/2025.
Amdocs Stock Performance
Shares of DOX traded down $0.70 during mid-day trading on Friday, hitting $83.79. The stock had a trading volume of 1,066,788 shares, compared to its average volume of 766,165. The company has a market cap of $9.46 billion, a PE ratio of 17.00, a PEG ratio of 1.54 and a beta of 0.54. The company's fifty day simple moving average is $86.52 and its two-hundred day simple moving average is $88.43. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a fifty-two week low of $78.61 and a fifty-two week high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The business had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the firm posted $1.62 EPS. The business's revenue for the quarter was down 8.4% compared to the same quarter last year. On average, equities analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 annualized dividend and a yield of 2.5%. Amdocs's payout ratio is currently 42.80%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on DOX shares. Wolfe Research started coverage on Amdocs in a research report on Tuesday, July 8th. They set an "outperform" rating on the stock. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, Amdocs currently has an average rating of "Buy" and a consensus price target of $105.33.
View Our Latest Research Report on Amdocs
Institutional Investors Weigh In On Amdocs
A number of hedge funds and other institutional investors have recently bought and sold shares of DOX. Pzena Investment Management LLC boosted its position in Amdocs by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company's stock valued at $597,719,000 after buying an additional 132,463 shares during the last quarter. LSV Asset Management boosted its position in Amdocs by 6.6% in the 2nd quarter. LSV Asset Management now owns 3,391,510 shares of the technology company's stock valued at $309,441,000 after buying an additional 211,009 shares during the last quarter. Alyeska Investment Group L.P. boosted its position in Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock valued at $213,174,000 after buying an additional 648,693 shares during the last quarter. Brandes Investment Partners LP boosted its position in Amdocs by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,328,804 shares of the technology company's stock valued at $212,481,000 after buying an additional 27,581 shares during the last quarter. Finally, American Century Companies Inc. boosted its position in shares of Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock worth $205,219,000 after purchasing an additional 426,911 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About Amdocs
(
Get Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report